Venture Partner / Corporate Strategy, Luminous Ventures / Synthace Ltd
Peter is a scientist, who a couple of years ago made the plunge into the world of technology. As such, he approaches the world of technology investing scientifically with a focus on evidence, rather than euphoria. Whilst, the language, timings and inflexions in deep technology companies may differ to those in therapeutics; understanding of the patient or customer need, and a clear capital efficient plan to de-risk are commonalities.
He currently works in corporate strategy at Synthace (a series-B software/ SynBio company) where he leads the go-to-market in cell & gene therapy, international expansion and market thought leadership. He is also a Venture Partner at Luminous Ventures, a Pan-EU deep technology fund with a focus on life-sciences, agritech and software platforms.
Before, his current roles Peter obtained a DPhil in Chemical Biology from Oxford University, an MChem from Warwick University, experience in biopharma R&D and spent over a year working in a pharma investing role.
Having been involved in many accelerators during his studies (and benefiting massively from them), Peter is passionate about giving back to the early stage healthcare/life-sciences ecosystem, wherever possible.
(+44) 1223 496 000
Babraham Bioscience Technologies Ltd
Babraham Research Campus
CB22 3AT, United Kingdom
01223 813 557